JP2009537246A5 - - Google Patents

Download PDF

Info

Publication number
JP2009537246A5
JP2009537246A5 JP2009511194A JP2009511194A JP2009537246A5 JP 2009537246 A5 JP2009537246 A5 JP 2009537246A5 JP 2009511194 A JP2009511194 A JP 2009511194A JP 2009511194 A JP2009511194 A JP 2009511194A JP 2009537246 A5 JP2009537246 A5 JP 2009537246A5
Authority
JP
Japan
Prior art keywords
pharmaceutical formulation
treprostinil
metered dose
kit
dose inhaler
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009511194A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009537246A (ja
JP5797376B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/068884 external-priority patent/WO2007134292A2/en
Publication of JP2009537246A publication Critical patent/JP2009537246A/ja
Publication of JP2009537246A5 publication Critical patent/JP2009537246A5/ja
Application granted granted Critical
Publication of JP5797376B2 publication Critical patent/JP5797376B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009511194A 2006-05-15 2007-05-14 定量吸入器を用いたトレプロスチニル投与 Active JP5797376B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80001606P 2006-05-15 2006-05-15
US60/800,016 2006-05-15
PCT/US2007/068884 WO2007134292A2 (en) 2006-05-15 2007-05-14 Treprostinil administration using a metered dose inhaler

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2013185229A Division JP2014114269A (ja) 2006-05-15 2013-09-06 定量吸入器を用いたトレプロスチニル投与
JP2015142794A Division JP2016006066A (ja) 2006-05-15 2015-07-17 定量吸入器を用いたトレプロスチニル投与

Publications (3)

Publication Number Publication Date
JP2009537246A JP2009537246A (ja) 2009-10-29
JP2009537246A5 true JP2009537246A5 (enExample) 2010-06-17
JP5797376B2 JP5797376B2 (ja) 2015-10-21

Family

ID=38544006

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2009511194A Active JP5797376B2 (ja) 2006-05-15 2007-05-14 定量吸入器を用いたトレプロスチニル投与
JP2013185229A Withdrawn JP2014114269A (ja) 2006-05-15 2013-09-06 定量吸入器を用いたトレプロスチニル投与
JP2015142794A Withdrawn JP2016006066A (ja) 2006-05-15 2015-07-17 定量吸入器を用いたトレプロスチニル投与
JP2019038370A Pending JP2019112434A (ja) 2006-05-15 2019-03-04 定量吸入器を用いたトレプロスチニル投与

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2013185229A Withdrawn JP2014114269A (ja) 2006-05-15 2013-09-06 定量吸入器を用いたトレプロスチニル投与
JP2015142794A Withdrawn JP2016006066A (ja) 2006-05-15 2015-07-17 定量吸入器を用いたトレプロスチニル投与
JP2019038370A Pending JP2019112434A (ja) 2006-05-15 2019-03-04 定量吸入器を用いたトレプロスチニル投与

Country Status (8)

Country Link
US (10) US20080200449A1 (enExample)
EP (1) EP2026816B1 (enExample)
JP (4) JP5797376B2 (enExample)
KR (1) KR101390579B1 (enExample)
CN (1) CN101495122B (enExample)
CA (1) CA2654492C (enExample)
ES (1) ES2707548T3 (enExample)
WO (1) WO2007134292A2 (enExample)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007532663A (ja) * 2004-04-12 2007-11-15 ユナイテッド セラピューティクス インコーポレイテッド ニューロパシー性の糖尿病性足潰瘍を治療するためのトレプロスチニルの使用
KR101390579B1 (ko) 2006-05-15 2014-05-19 유나이티드 세러퓨틱스 코오포레이션 정량 흡입기를 사용한 트레프로스티닐 투여
DE102006026786A1 (de) 2006-06-07 2007-12-13 Joachim Kern Dosierinhalator
US20080280986A1 (en) * 2007-02-09 2008-11-13 United Therapeutics Corporation Treprostinil treatment for interstitial lung disease and asthma
CA2710205C (en) * 2007-12-17 2016-04-26 United Therapeutics Corporation An improved process to prepare treprostinil, the active ingredient in remodulin
WO2009115235A1 (en) * 2008-03-20 2009-09-24 Bayer Schering Pharma Aktiengesellschaft Pde inhibitors for the treatment of pulmonary hypertension
EP3002274A1 (en) 2008-05-08 2016-04-06 United Therapeutics Corporation Treprostinil monohydrate
EP2330893A4 (en) * 2008-09-25 2013-01-09 Aradigm Corp DEEP PULMONARY ADMINISTRATION OF TREPROSTINIL
CA2760499C (en) * 2009-05-07 2015-11-03 United Therapeutics Corporation Solid formulations of prostacyclin analogs
KR20180036807A (ko) 2009-06-12 2018-04-09 맨카인드 코포레이션 한정된 비표면적을 갖는 디케토피페라진 마이크로입자
ES2611187T3 (es) * 2010-03-15 2017-05-05 United Therapeutics Corporation Tratamiento para hipertensión pulmonar
CN103261142B (zh) 2010-06-03 2014-12-10 联合治疗公司 曲前列环素的制备
US20130345471A1 (en) 2011-03-02 2013-12-26 United Therapeutics Corporation Synthesis of intermediate for treprostinil production
WO2012146642A1 (en) * 2011-04-26 2012-11-01 Activaero Gmbh Administration of iloprost as aerosol bolus
CN103193626B (zh) 2012-01-10 2016-05-11 上海天伟生物制药有限公司 一种前列腺素类似物的晶型及其制备方法和用途
CN103193627B (zh) 2012-01-10 2016-04-20 上海天伟生物制药有限公司 一种前列腺素类似物的晶型及其制备方法和用途
US9387214B2 (en) 2012-01-13 2016-07-12 United Therapeutics Corporation Method of identifying therapies for pulmonary hypertension
ES2974809T3 (es) 2012-10-31 2024-07-01 Vectura Gmbh Administración de iloprost en aerosol
CA2890219A1 (en) * 2012-11-30 2014-06-05 Insmed Incorporated Prostacylin compositions and methods for using the same
JP6542128B2 (ja) 2013-01-11 2019-07-10 コルセア ファーマ インコーポレイテッド トレプロスチニルのプロドラッグ
US9505737B2 (en) 2013-01-11 2016-11-29 Corsair Pharma, Inc. Treprostinil derivative compounds and methods of using same
CA3125504C (en) 2013-03-14 2023-10-24 United Therapeutics Corporation Solid forms of treprostinil
AU2014228415B2 (en) 2013-03-15 2018-08-09 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
EP2970081A4 (en) 2013-03-15 2016-10-12 United Therapeutics Corp SALTS OF TREPROSTINIL
WO2014160638A1 (en) 2013-03-25 2014-10-02 United Therapeutics Corporation Process of making prostacyclin compounds with linker thiol and pegylated forms
CA2918369C (en) 2013-07-18 2021-06-29 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
SI3060041T1 (sl) 2013-10-25 2021-04-30 Insmed Incorporated Spojine prostaciklina
EP3082428A4 (en) 2013-12-09 2017-08-02 Respira Therapeutics, Inc. Pde5 inhibitor powder formulations and methods relating thereto
CA2952223C (en) 2014-06-13 2023-08-01 United Therapeutics Corporation Treprostinil formulations
WO2016064764A1 (en) 2014-10-20 2016-04-28 United Therapeutics Corporation Synthesis of intermediate for producing prostacyclin derivatives
AU2015349969B2 (en) 2014-11-18 2020-02-06 Insmed Incorporated Methods of manufacturing treprostinil and treprostinil derivative prodrugs
EP3226838A1 (en) 2014-12-03 2017-10-11 Steadymed Ltd. Preservative-free treprostinil formulations and methods and devices for use with same
US9643911B2 (en) 2015-06-17 2017-05-09 Corsair Pharma, Inc. Treprostinil derivatives and compositions and uses thereof
US9394227B1 (en) 2015-06-17 2016-07-19 Corsair Pharma, Inc. Treprostinil derivatives and compositions and uses thereof
US20190321290A1 (en) * 2016-01-29 2019-10-24 Mannkind Corporation Composition and method for inhalation
EP4079291A1 (en) * 2016-01-29 2022-10-26 MannKind Corporation Dry powder inhaler
JP2019519489A (ja) 2016-05-05 2019-07-11 リクイディア・テクノロジーズ・インコーポレーテッド 肺高血圧症を治療するための乾燥粉末トレプロスチニル
CA3038276A1 (en) 2016-09-26 2018-03-29 United Therapeutics Corporation Treprostinil prodrugs
US10912778B2 (en) 2016-12-14 2021-02-09 Respira Therapeutics, Inc. Methods for treatment of pulmonary hypertension
US10799653B2 (en) 2017-01-09 2020-10-13 United Therapeutics Corporation Aerosol delivery device and method for manufacturing and operating the same
US10702495B2 (en) 2017-02-20 2020-07-07 Nexien Biopharma, Inc. Method and compositions for treating dystrophies and myotonia
MX2020011323A (es) * 2018-05-07 2020-11-18 Pharmosa Biopharm Inc Composicion farmaceutica para liberacion controlada de treprostinil.
KR102259824B1 (ko) * 2018-07-24 2021-06-02 주식회사 마더스제약 보센탄을 함유한 약학 제제
IL280891B1 (en) 2018-09-18 2025-09-01 Lilly Co Eli Treprostinil erbumine salt
CN114072136B (zh) 2019-04-29 2024-11-29 英斯梅德股份有限公司 曲前列素前药的干粉组合物及其使用方法
EP3750528A1 (en) 2019-06-11 2020-12-16 Nexien Biopharma, Inc. Compositions for treating dystrophies and myotonia
AU2020316931A1 (en) 2019-07-22 2022-02-24 Nanomi, B.V. Sustained release treprostinil-compound microparticle compositions
CN114616225A (zh) 2019-08-23 2022-06-10 联合治疗公司 曲前列环素前药
CN112569210B (zh) * 2019-09-27 2023-09-15 盈科瑞(天津)创新医药研究有限公司 一种吸入用马昔腾坦溶液及其制备方法
JP7727652B2 (ja) 2020-03-31 2025-08-21 インヴォックス ベルジアム エヌヴイ 少なくとも2つの液体組成物のエアロゾル送達
WO2021211916A1 (en) 2020-04-17 2021-10-21 United Therapeutics Corporation Treprostinil for use in the treatment of intersitial lung disease
US11013688B1 (en) * 2020-05-28 2021-05-25 Softhale Nv Methods of treatment of viral diseases
US11793780B2 (en) 2020-06-09 2023-10-24 United Therapeutics Corporation Prodrugs of treprosiinil
US20220152025A1 (en) 2020-11-17 2022-05-19 United Therapeutics Corporation Inhaled imatinib for pulmonary hypertension
WO2022132655A1 (en) 2020-12-14 2022-06-23 United Therapeutics Corporation Methods of treating disease with treprostinil prodrugs
EP4301372A1 (en) 2021-03-03 2024-01-10 United Therapeutics Corporation A dry powder composition of trestinil and its prodrug thereof and further comprising comprising (e)-3,6-bis[4-(n-carbonyl-2-propenyl)amidobutyl]-2,5-diketopiperazine (fdkp)
CN113876748A (zh) * 2021-11-22 2022-01-04 兆科药业(广州)有限公司 一种用于治疗肺动脉高压的曲前列尼尔气溶胶吸入剂的雾化方法
KR20240136408A (ko) 2022-01-21 2024-09-13 인보엑스 벨지엄 엔브이 폐 고혈압을 치료하기 위한 트레프로스티닐
JP2025506019A (ja) * 2022-02-08 2025-03-05 ユナイテッド セラピューティクス コーポレイション トレプロスチニルイロプロスト併用療法
KR20250002687A (ko) * 2022-04-29 2025-01-07 자오커 파마슈티컬 (광저우) 컴퍼니., 리미티드 트레프로스티닐 소프트 미스트 흡입제
EP4652151A1 (en) 2023-01-19 2025-11-26 United Therapeutics Corporation Treprostinil analogs
WO2025101824A1 (en) 2023-11-09 2025-05-15 United Therapeutics Corporation Syntheses of compounds useful for producing treprostinil

Family Cites Families (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3664337A (en) 1970-04-15 1972-05-23 Bio Logics Inc Respiration assembly and methods
US4001650A (en) 1975-09-02 1977-01-04 Puritan-Bennett Corporation Method and apparatus for ultrasonic transducer protection
US4007238A (en) 1976-02-25 1977-02-08 Glenn Joseph G Nebulizer for use with IPPB equipment
US4473296A (en) 1978-05-03 1984-09-25 Ppm, Inc. System and method and apparatus for a continuous aerosol monitor (CAM) using electro-optical weighing for general aerosols
DE2845770A1 (de) * 1978-10-19 1980-04-30 Schering Ag Neue prostacyclin-derivate und verfahren zu ihrer herstellung
US4281113A (en) * 1979-07-31 1981-07-28 The Upjohn Company 2,5-Inter-o-phenylene-3,4-dinor-6,9α-epoxy-6.beta.-5-iodo-PGF1 compounds
US4306075A (en) * 1980-03-28 1981-12-15 The Upjohn Company Composition and process
US4306076A (en) * 1980-04-23 1981-12-15 The Upjohn Company Inter-phenylene CBA compounds
DE3048906A1 (de) * 1980-12-19 1982-07-15 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4349689A (en) * 1980-12-22 1982-09-14 The Upjohn Company Methano carbacyclin analogs
US4486598A (en) * 1982-02-22 1984-12-04 The Upjohn Company Carbacyclin analogs
US4495944A (en) 1983-02-07 1985-01-29 Trutek Research, Inc. Inhalation therapy apparatus
US4668814A (en) * 1984-03-08 1987-05-26 The Upjohn Company Interphenylene carbacyclin derivatives
US4683330A (en) * 1984-03-08 1987-07-28 The Upjohn Company Interphenylene carbacyclin derivatives
US4635647A (en) 1984-09-07 1987-01-13 Choksi Pradip V Incentive spirometer employing bellows air flow sensor
NZ209900A (en) 1984-10-16 1989-08-29 Univ Auckland Automatic inhaler
US4976259A (en) 1986-12-22 1990-12-11 Mountain Medical Equipment, Inc. Ultrasonic nebulizer
US5322057A (en) 1987-07-08 1994-06-21 Vortran Medical Technology, Inc. Intermittent signal actuated nebulizer synchronized to operate in the exhalation phase, and its method of use
US5080093A (en) 1987-07-08 1992-01-14 Vortran Medical Technology, Inc. Intermittant signal actuated nebulizer
FI82808C (fi) 1987-12-31 1991-04-25 Etelae Haemeen Keuhkovammayhdi Ultraljudfinfoerdelningsanordning.
GB8814438D0 (en) * 1988-06-17 1988-07-20 Wellcome Found Compounds for use in medicine
US4984158A (en) 1988-10-14 1991-01-08 Hillsman Dean Metered dose inhaler biofeedback training and evaluation system
GB9011588D0 (en) * 1990-05-24 1990-07-11 Wellcome Found Prostaglandin analogues for use in medicine
ES2284226T3 (es) 1991-07-02 2007-11-01 Nektar Therapeutics Dispositivo para proporcionar medicamentos en aerosol.
GB2291605B (en) 1991-11-12 1996-05-01 Medix Ltd A nebuliser and nebuliser control system
US5363842A (en) 1991-12-20 1994-11-15 Circadian, Inc. Intelligent inhaler providing feedback to both patient and medical professional
FR2694215B1 (fr) 1992-07-30 1994-10-21 Dp Medical Appareil pour générer un brouillard à partir d'un liquide, notamment un médicament.
WO1994008727A1 (en) 1992-10-16 1994-04-28 Sheiman Ultrasonic Research Foundation Pty Ltd Ultrasonic nebulising device
US5497763A (en) 1993-05-21 1996-03-12 Aradigm Corporation Disposable package for intrapulmonary delivery of aerosolized formulations
GB9301192D0 (en) * 1993-06-09 1993-06-09 Trott Francis W Flower shaped mechanised table
US5752502A (en) 1993-12-16 1998-05-19 King; Russell Wayne General purpose aerosol inhalation apparatus
AU735975B2 (en) 1995-02-27 2001-07-19 Toray Industries, Inc. Remedy for pulmonary heart
US5881715A (en) 1995-07-10 1999-03-16 A & D Company, Limited Handy type atomizer
FR2746656B1 (fr) 1996-03-26 1999-05-28 System Assistance Medical Nebuliseur a capteur de pression
US6441245B1 (en) 1997-10-24 2002-08-27 United Therapeutics Corporation Process for stereoselective synthesis of prostacyclin derivatives
EP1045695B1 (en) 1997-11-14 2004-03-24 United Therapeutics Corporation Use of 9-deoxy-2', 9-alpha-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin f 1? to treat peripheral vascular disease
DE19838711C1 (de) 1998-08-26 2000-06-21 Otto Schill Gmbh & Co Kg Inhalator zum Vernebeln von Flüssigkeiten
FR2783431B1 (fr) 1998-09-23 2001-02-02 System Assistance Medical Nebuliseur permettant de delivrer un brouillard a un patient et procede de fonctionnement d'un tel nebuliseur
SE9900369D0 (sv) * 1999-02-04 1999-02-04 Siemens Elema Ab Ultrasonic nebuliser
US6521212B1 (en) * 1999-03-18 2003-02-18 United Therapeutics Corporation Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalation
DE19934582C2 (de) 1999-07-23 2003-09-18 Otto Schill Gmbh & Co Kg Aerosolerzeuger
US8464706B2 (en) 2000-02-11 2013-06-18 Respironics Respiratory Drug Delivery (Uk) Ltd Drug delivery apparatus
DE10022795B4 (de) 2000-05-10 2005-04-14 Pari GmbH Spezialisten für effektive Inhalation Atemgesteuertes Inhalationstherapiegerät
US6242482B1 (en) 2000-06-05 2001-06-05 United Therapeutics Corporation Prostaglandin compounds and derivatives thereof, compositions containing the same and method of using the same for the treatment of congestive heart failure
JP2004512101A (ja) * 2000-10-20 2004-04-22 グラクソ グループ リミテッド 吸入器
US6700025B2 (en) 2001-01-05 2004-03-02 United Therapeutics Corporation Process for stereoselective synthesis of prostacyclin derivatives
NZ532220A (en) 2001-09-12 2006-02-24 Norton Healthcare Ltd Breath-enhanced ultrasonic nebulizer and dedicated unit dose ampoule
US6626843B2 (en) 2001-09-28 2003-09-30 Deane Hillsman Respiratory timing and lung deflation method and device
US6803386B2 (en) 2002-01-16 2004-10-12 United Therapeutics Corporation Prostacyclin derivative containing compositions and methods of using the same for the treatment of cancer
US20040063912A1 (en) * 2002-03-15 2004-04-01 The Brigham And Women's Hospital, Inc. Central airway administration for systemic delivery of therapeutics
US20030192532A1 (en) 2002-04-12 2003-10-16 Hopkins Andrew David Nebulizer
US7550133B2 (en) * 2002-11-26 2009-06-23 Alexza Pharmaceuticals, Inc. Respiratory drug condensation aerosols and methods of making and using them
AU2003293197A1 (en) 2002-12-02 2004-06-23 Scott Laboratories, Inc. Respiratory monitoring systems and methods
US7726303B2 (en) 2003-02-25 2010-06-01 Hewlett-Packard Development Company, L.P. Controlled medicament ejection
ES2622471T5 (es) * 2003-05-22 2020-07-23 United Therapeutics Corp Compuestos y procedimientos para la administración de análogos de prostaciclina
US20040265238A1 (en) * 2003-06-27 2004-12-30 Imtiaz Chaudry Inhalable formulations for treating pulmonary hypertension and methods of using same
JP4357230B2 (ja) * 2003-07-14 2009-11-04 帝人株式会社 酸素濃縮装置、在宅酸素療法システム
US7172557B1 (en) 2003-08-29 2007-02-06 Caldyne, Inc. Spirometer, display and method
DE602004028155D1 (de) 2003-12-16 2010-08-26 United Therapeutics Corp Verwendung von treprostinil zur behandlung von ischämischen läsionen
ES2331187T3 (es) 2003-12-16 2009-12-23 United Therapeutics Corporation Utilizacion de treprostinil para mejorar las funciones renales.
US7380550B2 (en) 2004-01-30 2008-06-03 Hewlett-Packard Development Company, L.P. Systems and methods for particle detection
DE102004009436A1 (de) 2004-02-24 2005-10-13 Boehringer Ingelheim International Gmbh Zerstäuber
WO2006014930A2 (en) * 2004-07-26 2006-02-09 Cotherix, Inc. Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation
US7721729B2 (en) 2005-03-09 2010-05-25 Ric Investments, Llc Nebulizing drug delivery device for ventilator
KR101390579B1 (ko) 2006-05-15 2014-05-19 유나이티드 세러퓨틱스 코오포레이션 정량 흡입기를 사용한 트레프로스티닐 투여
DE102006026786A1 (de) 2006-06-07 2007-12-13 Joachim Kern Dosierinhalator
US20090036465A1 (en) 2006-10-18 2009-02-05 United Therapeutics Corporation Combination therapy for pulmonary arterial hypertension
US20080280986A1 (en) 2007-02-09 2008-11-13 United Therapeutics Corporation Treprostinil treatment for interstitial lung disease and asthma
EP2330893A4 (en) 2008-09-25 2013-01-09 Aradigm Corp DEEP PULMONARY ADMINISTRATION OF TREPROSTINIL
CA2760499C (en) 2009-05-07 2015-11-03 United Therapeutics Corporation Solid formulations of prostacyclin analogs

Similar Documents

Publication Publication Date Title
JP2009537246A5 (enExample)
JP5571867B2 (ja) 肺高血圧治療のための吸入可能製剤およびその使用方法
AU775588B2 (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
JP5797376B2 (ja) 定量吸入器を用いたトレプロスチニル投与
JP2019528320A5 (enExample)
RU2019100425A (ru) Новая доза и препаративная форма
JP2004538303A5 (enExample)
CA2782734C (en) Nicotine containing formulation
JP2008512363A (ja) 経粘膜投与製剤の吸収を高める方法
JP2019531308A5 (enExample)
KR20140049001A (ko) 조성물
JP2007525533A5 (enExample)
CN119700755A (zh) 化合物在制备预防和/或治疗高原病的药物中的应用
HK1093017B (en) Inhalable formulations for treating pulmonary hypertension and methods of using same
JPH04164033A (ja) 心臓疾患の予防または治療剤